Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

Cleo Diagnostics Ltd

Healthcare AU COV

0.35AUD
-(-%)

Last update at 2025-06-20T05:24:00Z

Day Range

0.350.35
LowHigh

52 Week Range

0.290.62
LowHigh

Fundamentals

  • Previous Close 0.35
  • Market Cap44.98M
  • Volume11987
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.13907M
  • Revenue TTM0.21M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM 0.21M
  • Diluted EPS TTM-0.03

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown
Breakdown
Breakdown

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
COV
Cleo Diagnostics Ltd		 - -% 0.35 - - 213.34 6.04
COH
Cochlear Ltd		 7.21 2.50% 295.64 51.08 41.84 8.07 9.86 7.92 30.61
PNV
Polynovo Ltd		 0.01 1.24% 1.22 121.00 57.47 7.20 11.03 7.09 89.08
IMR
Imricor Medical Systems Inc		 -0.015 0.98% 1.51 - - 511.02 3.97 336.99 -2.6027
EBR
Ebr Systems Inc CDR		 - -% 1.08 - - - 17.93 -3.6785

Reports Covered

Stock Research & News

View All

Profile

Cleo Diagnostics Ltd, a medical diagnostics and devices company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company provides CleoDX pre-surgical triage tests which measures a combination of biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property and patents. The company was incorporated in 2021 and is based in Melbourne, Australia.

Cleo Diagnostics Ltd

480 Collins Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Dr. Richard Allman Ph.D. CEO & Exec. Director 1960
Dr. Andrew N. Stephens Chief Scientific Officer & Exec. Director NA
Prof. Thomas William Jobling Lead Medical Advisor & Independent Non-Exec. Director NA
Ms. Pauline M. Moffatt AAICD, B.Com., BCom, FGIA Company Sec. NA
Dr. Richard Allman Ph.D. CEO & Exec. Director 1960
Dr. Andrew N. Stephens Chief Scientific Officer & Exec. Director NA
Prof. Thomas William Jobling Lead Medical Advisor & Independent Non-Exec. Director NA
Ms. Pauline M. Moffatt AAICD, B.Com., BCom, FGIA Company Sec. NA
Dr. Richard Allman Ph.D. CEO & Exec. Director 1960
Dr. Andrew N. Stephens Chief Scientific Officer & Exec. Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.